D.E. Shaw & Co

D.E. Shaw & Co’s Surrozen SRZN Stock Holding History

D.E. Shaw & Co’s Portfolio SRZN Stock Details SRZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,377	Closed	-$205K	–	5214
2021 Q2	$205K	Buy	+1,377	New	+$204K	﹤0.01%	4445

Other funds holding SRZN

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Trustees of Columbia University in the City of New York New York $891M AUM 17.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

D.E. Shaw & Co's SRZN Position: Q3 2021 in Review

D.E. Shaw & Co sold out of Surrozen (SRZN) in Q3 2021, closing a stake of 1,377 shares — an estimated $205K sold.

D.E. Shaw & Co first reported a position in SRZN in Q2 2021 and held it in 1 quarter. The position peaked at $205K in Q2 2021. 28 funds tracked by Wall St. Rank hold SRZN as of Q3 2021.

D.E. Shaw & Co reported no remaining Surrozen position as of Q3 2021 after selling out during the quarter.
D.E. Shaw & Co sold 1,377 Surrozen shares in Q3 2021, an estimated $205K.
D.E. Shaw & Co first reported a position in Surrozen in Q2 2021 and held it in 1 quarter.
D.E. Shaw & Co's Surrozen position peaked at $205K in Q2 2021.
28 funds tracked by Wall St. Rank held Surrozen as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.